Olema Pharmaceuticals, Inc.
For the period ended Apr 28, 2025. Filed Apr 28, 2025.
View on SEC.govAbout this filing
What shareholders are asked to vote on at a company's meeting. It is where to find what directors and top executives are paid, and who owns the most shares.
Apr 28, 2025 · Filed Apr 28, 2025
OLMA$7.33+8.4%Stored close · as of Nov 6, 2026
Contents
Table of Contents
| | Page |
|---|---|
| QUESTIONS AND ANSWERS ABOUT THESE PROXY MATERIALS AND VOTING | 1 |
| PROPOSAL NO. 1 ELECTION OF DIRECTORS | 8 |
| CORPORATE GOVERNANCE AND BOARD MATTERS | 12 |
| PROPOSAL NO. 2 ADVISORY VOTE ON EXECUTIVE COMPENSATION | 20 |
| PROPOSAL NO. 3 RATIFICATION OF SELECTION OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM | 21 |
| SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT | 22 |
| EXECUTIVE OFFICERS | 26 |
| EXECUTIVE COMPENSATION | 28 |
| PAY VERSUS PERFORMANCE | 36 |
| EQUITY COMPENSATION PLAN INFORMATION | 41 |
| DIRECTOR COMPENSATION | 43 |
| TRANSACTIONS WITH RELATED PERSONS AND INDEMNIFICATION | 45 |
| DELINQUENT SECTION 16(A) REPORTS | 48 |
| HOUSEHOLDING OF PROXY MATERIALS | 48 |
| OTHER MATTERS | 50 |
OLEMA PHARMACEUTICALS, INC.
780 Brannan Street
San Francisco, California 94103
PROXY STATEMENT
FOR THE 2025 ANNUAL MEETING OF STOCKHOLDERS
JUNE 10, 2025
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.